Literature DB >> 10722614

Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia.

P E Dekkers1, T ten Hove, A A te Velde, S J van Deventer, T van Der Poll.   

Abstract

The receptor for urokinase-type plasminogen activator (uPAR) (CD87) plays an important role in leukocyte adhesion and migration. To assess the effect of endotoxin on cellular uPAR, uPAR expression was determined on leukocytes by fluorescence-activated cell sorter analysis in seven healthy subjects following intravenous injection of endotoxin (lot G; 4 ng/kg). Endotoxin induced a transient increase in uPAR expression on monocytes, reaching a 92% +/- 46% increase over baseline expression after 6 h (P < 0.05). Endotoxin did not influence uPAR expression on granulocytes, while uPAR remained undetectable on lymphocytes. Endotoxin also increased soluble uPAR levels in plasma (P < 0.05). Stimulation of human whole blood with endotoxin or gram-positive stimuli in vitro also resulted in an upregulation of monocyte uPAR expression. Although tumor necrosis factor alpha (TNF) upregulated monocyte uPAR expression, anti-TNF did not influence the endotoxin-induced increase in monocyte uPAR expression. These data suggest that infectious stimuli may influence monocyte function in vivo by enhancing the expression of uPAR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722614      PMCID: PMC97398          DOI: 10.1128/IAI.68.4.2156-2160.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Leukocyte-endothelial adhesion molecules.

Authors:  T M Carlos; J M Harlan
Journal:  Blood       Date:  1994-10-01       Impact factor: 22.113

2.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

3.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

4.  The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils.

Authors:  T Plesner; M Ploug; V Ellis; E Rønne; G Høyer-Hansen; M Wittrup; T L Pedersen; T Tscherning; K Danø; N E Hansen
Journal:  Blood       Date:  1994-02-01       Impact factor: 22.113

5.  The urokinase receptor is required for human monocyte chemotaxis in vitro.

Authors:  M R Gyetko; R F Todd; C C Wilkinson; R G Sitrin
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

Authors:  N Pedersen; M Schmitt; E Rønne; M I Nicoletti; G Høyer-Hansen; M Conese; R Giavazzi; K Dano; W Kuhn; F Jänicke
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes.

Authors:  W Xue; A L Kindzelskii; R F Todd; H R Petty
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

8.  Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes.

Authors:  R G Sitrin; R F Todd; I F Mizukami; T J Gross; S B Shollenberger; M R Gyetko
Journal:  Blood       Date:  1994-08-15       Impact factor: 22.113

9.  A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  M Ploug; J Eriksen; T Plesner; N E Hansen; K Danø
Journal:  Eur J Biochem       Date:  1992-09-01

10.  Urokinase receptor. An activation antigen in human T lymphocytes.

Authors:  A Nykjaer; B Møller; R F Todd; T Christensen; P A Andreasen; J Gliemann; C M Petersen
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

View more
  19 in total

1.  Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia.

Authors:  N P Juffermans; P E Dekkers; A Verbon; P Speelman; S J van Deventer; T van der Poll
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Identification of diagnostic biomarkers for infection in premature neonates.

Authors:  Stephen F Kingsmore; Neil Kennedy; Henry L Halliday; Jennifer C Van Velkinburgh; Shengiang Zhong; Vanessa Gabriel; Judith Grant; William D Beavis; Velizar T Tchernev; Lorah Perlee; Serguei Lejnine; Brian Grimwade; Martin Sorette; J David M Edgar
Journal:  Mol Cell Proteomics       Date:  2008-07-13       Impact factor: 5.911

3.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Authors:  Changli Wei; Shafic El Hindi; Jing Li; Alessia Fornoni; Nelson Goes; Junichiro Sageshima; Dony Maiguel; S Ananth Karumanchi; Hui-Kim Yap; Moin Saleem; Qingyin Zhang; Boris Nikolic; Abanti Chaudhuri; Pirouz Daftarian; Eduardo Salido; Armando Torres; Moro Salifu; Minnie M Sarwal; Franz Schaefer; Christian Morath; Vedat Schwenger; Martin Zeier; Vineet Gupta; David Roth; Maria Pia Rastaldi; George Burke; Phillip Ruiz; Jochen Reiser
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

4.  Participation of the urokinase receptor in neutrophil efferocytosis.

Authors:  Young-Jun Park; Gang Liu; Yuko Tsuruta; Emmanuel Lorne; Edward Abraham
Journal:  Blood       Date:  2009-04-27       Impact factor: 22.113

5.  The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.

Authors:  Jun Sato; Jeffrey Schorey; Victoria A Ploplis; Erijka Haalboom; Liana Krahule; Francis J Castellino
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

6.  Expression of the urokinase plasminogen activator receptor (uPAR) and its ligand (uPA) in brain tissues of human immunodeficiency virus patients with opportunistic cerebral diseases.

Authors:  Manuela Nebuloni; Paola Cinque; Nicolai Sidenius; Angelita Ferri; Eleonora Lauri; Elisabetta Omodeo-Zorini; Pietro Zerbi; Luca Vago
Journal:  J Neurovirol       Date:  2008-12-24       Impact factor: 2.643

Review 7.  Serum suPAR in patients with FSGS: trash or treasure?

Authors:  Rutger J H Maas; Jeroen K J Deegens; Jack F M Wetzels
Journal:  Pediatr Nephrol       Date:  2013-03-21       Impact factor: 3.714

8.  Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood.

Authors:  Line Jee Hartmann Rasmussen; Terrie E Moffitt; Jesper Eugen-Olsen; Daniel W Belsky; Andrea Danese; HonaLee Harrington; Renate M Houts; Richie Poulton; Karen Sugden; Benjamin Williams; Avshalom Caspi
Journal:  J Child Psychol Psychiatry       Date:  2018-05-09       Impact factor: 8.982

9.  Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment.

Authors:  Paulo Rabna; Andreas Andersen; Christian Wejse; Ines Oliveira; Victor Francisco Gomes; Maya Bonde Haaland; Peter Aaby; Jesper Eugen-Olsen
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

10.  Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.

Authors:  Orla Cunningham; Suzanne Campion; V Hugh Perry; Carol Murray; Nicolai Sidenius; Fabian Docagne; Colm Cunningham
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.